About the Authors

Tingxiu Xiang

Affiliation Molecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Lili Li

Affiliation Cancer Epigenetics Laboratory, Department of Clinical Oncology, Sir YK Pao Center for Cancer, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China

Xuedong Yin

Affiliation Molecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Chenfu Yuan

Affiliation Molecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Cui Tan

Affiliation Molecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Xianwei Su

Affiliation Cancer Epigenetics Laboratory, Department of Clinical Oncology, Sir YK Pao Center for Cancer, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China

Lei Xiong

Affiliation Cancer Epigenetics Laboratory, Department of Clinical Oncology, Sir YK Pao Center for Cancer, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China

Thomas C. Putti

Affiliation Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Michael Oberst

Affiliation Signal Transduction Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

Kathleen Kelly

Affiliation Signal Transduction Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

Guosheng Ren

rgs726@163.com (GR); qtao@clo.cuhk.edu.hk (QT)

Affiliation Molecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Qian Tao

rgs726@163.com (GR); qtao@clo.cuhk.edu.hk (QT)

Affiliations Molecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China, Cancer Epigenetics Laboratory, Department of Clinical Oncology, Sir YK Pao Center for Cancer, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: QT. Performed the experiments: TX XY CY CT XS LX. Analyzed the data: TX LL GR QT. Contributed reagents/materials/analysis tools: TP MO KK GR XS LX. Wrote the paper: XT LL QT.